Podack ER - Search Results

1

Tumor immunogenicity and responsiveness to cancer vaccine therapy: the state of the art.

Schreiber TH, Raez L, Rosenblatt JD, Podack ER. Schreiber TH, et al. Among authors: podack er. Semin Immunol. 2010 Jun;22(3):105-12. doi: 10.1016/j.smim.2010.02.001. Epub 2010 Mar 11. Semin Immunol. 2010. PMID: 20226686 Free PMC article. Review.

2

Present and future of lung cancer vaccines.

Raez LE, Rosenblatt JD, Podack ER. Raez LE, et al. Among authors: podack er. Expert Opin Emerg Drugs. 2006 Sep;11(3):445-59. doi: 10.1517/14728214.11.3.445. Expert Opin Emerg Drugs. 2006. PMID: 16939384 Review.

3

Tumor antigen specific iTreg accumulate in the tumor microenvironment and suppress therapeutic vaccination.

Schreiber TH, Wolf D, Bodero M, Podack E. Schreiber TH, et al. Oncoimmunology. 2012 Aug 1;1(5):642-648. doi: 10.4161/onci.20298. Oncoimmunology. 2012. PMID: 22934256 Free PMC article.

4

A critical analysis of the tumour immunosurveillance controversy for 3-MCA-induced sarcomas.

Schreiber TH, Podack ER. Schreiber TH, et al. Among authors: podack er. Br J Cancer. 2009 Aug 4;101(3):381-6. doi: 10.1038/sj.bjc.6605198. Br J Cancer. 2009. PMID: 19638986 Free PMC article. Review.

5

Heat shock protein-based cancer vaccines.

Lee KP, Raez LE, Podack ER. Lee KP, et al. Among authors: podack er. Hematol Oncol Clin North Am. 2006 Jun;20(3):637-59. doi: 10.1016/j.hoc.2006.02.007. Hematol Oncol Clin North Am. 2006. PMID: 16762728 Review.

6

Allogeneic tumor-cell-based vaccines secreting endoplasmic reticulum chaperone gp96.

Podack ER, Raez LE. Podack ER, et al. Expert Opin Biol Ther. 2007 Nov;7(11):1679-88. doi: 10.1517/14712598.7.11.1679. Expert Opin Biol Ther. 2007. PMID: 17961091 Review.

7

Surmounting tumor-induced immune suppression by frequent vaccination or immunization in the absence of B cells.

Oizumi S, Deyev V, Yamazaki K, Schreiber T, Strbo N, Rosenblatt J, Podack ER. Oizumi S, et al. Among authors: podack er. J Immunother. 2008 May;31(4):394-401. doi: 10.1097/CJI.0b013e31816bc74d. J Immunother. 2008. PMID: 18391756

8

Tumor-induced suppression of CTL expansion and subjugation by gp96-Ig vaccination.

Schreiber TH, Deyev VV, Rosenblatt JD, Podack ER. Schreiber TH, et al. Among authors: podack er. Cancer Res. 2009 Mar 1;69(5):2026-33. doi: 10.1158/0008-5472.CAN-08-3706. Epub 2009 Feb 17. Cancer Res. 2009. PMID: 19223534 Free PMC article.

9

Immunotherapy as a strategy for the treatment of non-small-cell lung cancer.

Holt GE, Podack ER, Raez LE. Holt GE, et al. Among authors: podack er. Therapy. 2011 Jan;8(1):43-54. doi: 10.2217/thy.10.84. Therapy. 2011. PMID: 21359153 Free PMC article.

10

CD30: an important new target in hematologic malignancies.

Deutsch YE, Tadmor T, Podack ER, Rosenblatt JD. Deutsch YE, et al. Among authors: podack er. Leuk Lymphoma. 2011 Sep;52(9):1641-54. doi: 10.3109/10428194.2011.574761. Epub 2011 May 27. Leuk Lymphoma. 2011. PMID: 21619423 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

262 results

Search Page

Filters